# Lung Cancer Screening * **Definition:** A medical procedure, typically involving low-dose computed tomography (CT) scans, aimed at detecting lung cancer at an early stage in individuals who may not yet show symptoms, which is critical for effective treatment. * **Taxonomy:** Healthcare Topics / Lung Cancer Screening ## News * Selected news on the topic of **Lung Cancer Screening**, for healthcare technology leaders * 2.9K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/19/2025 | [**Arineta's SpotLight Duo CT Scanner Receives FDA Clearance for Low-Dose Lung Cancer Screening**](https://hitconsultant.net/2025/05/19/fda-clearance-enables-dual-heart-lung-screening-in-single-image/) | [[HIT Consultant]] | | 5/7/2025 | [**Tactics to Improve Lung Cancer Screening Rates: Raymond Osarogiagbon, MD**](https://www.ajmc.com/view/tactics-to-improve-lung-cancer-screening-rates-raymond-osarogiagbon-md) | [[AJMC]] | | 4/29/2025 | [**Barriers to Lung Cancer Screening Implementation in the US: Raymond Osarogiagbon, MD**](https://www.ajmc.com/view/barriers-to-lung-cancer-screening-implementation-in-the-us-raymond-osarogiagbon-md) | [[AJMC]] | | 4/22/2025 | [**The Growing Influence of Digital Health in Pharma - LinkedIn**](https://www.linkedin.com/pulse/growing-influence-digital-health-pharma-milan-sojitra-wgdwe) | [[Linkedin]] | | 4/3/2025 | [**Addressing low lung cancer screening rates through awareness and access**](https://www.news-medical.net/news/20250403/Addressing-low-lung-cancer-screening-rates-through-awareness-and-access.aspx) | [[News Medical Net]] | | 4/2/2025 | [**Lung cancer screening lags behind breast and colorectal screenings - Medical Xpress**](https://medicalxpress.com/news/2025-04-lung-cancer-screening-lags-breast.html) | [[MedicalXpress]] | | 4/2/2025 | [**Lung Cancer Screening Rates Nearly 4 Times Lower Than Breast, Colon Cancers**](https://www.medpagetoday.com/pulmonology/lungcancer/114945) | [[Medpage Today]] | | 4/2/2025 | [**Alfred J. Padilla, MD - KevinMD.com**](https://kevinmd.com/post-author/alfred-j-padilla) | [[KevinMD]] | | 3/2/2025 | [**DeepHealth brings AI-powered radiology informatics to ECR 2025 in Vienna**](https://www.news-medical.net/news/20250303/DeepHealth-brings-AI-powered-radiology-informatics-to-ECR-2025-in-Vienna.aspx) | [[News Medical Net]] | | 2/24/2025 | [**Coreline Soft Unveils the All-New AVIEW at ECR 2025--AI-Powered Lung Cancer Screening Redefined**](https://www.prnewswire.com/news-releases/coreline-soft-unveils-the-all-new-aview-at-ecr-2025ai-powered-lung-cancer-screening-redefined-302382167.html) | [[PR Newswire]] | | 1/28/2025 | [**Lung Cancer Screening Software Market Analysis by Size, Share, Growth, Trends and ...**](https://medium.com/@ahasan.univdatos/lung-cancer-screening-software-market-analysis-by-size-share-growth-trends-and-forecast-2b240f852244) | [[Medium]] | | 1/13/2025 | [**Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation**](https://www.medpagetoday.com/pulmonology/smoking/113764) | [[Medpage Today]] | | 11/4/2024 | [**Low awareness of lung cancer screening raises concerns**](https://www.news-medical.net/news/20241104/Low-awareness-of-lung-cancer-screening-raises-concerns.aspx) | [[News Medical Net]] | | 11/4/2024 | [**Ongoing survey data show awareness of lung cancer screening remains low**](https://medicalxpress.com/news/2024-11-ongoing-survey-awareness-lung-cancer.html) | [[MedicalXpress]] | | 11/4/2024 | [**Ongoing survey data show awareness of lung cancer screening remains low**](https://medicalxpress.com/news/2024-11-ongoing-survey-awareness-lung-cancer.html?deviceType=desktop) | [[MedicalXpress]] | | 11/4/2024 | [**$2.5 million grant supports lung cancer screening for marginalized communities**](https://www.news-medical.net/news/20241104/2425-million-grant-supports-lung-cancer-screening-for-marginalized-communities.aspx) | [[News Medical Net]] | | 11/1/2024 | [**Lung Cancer Screening May Detect Cancer Before Symptoms Show - PR Newswire**](https://www.prnewswire.com/news-releases/lung-cancer-screening-may-detect-cancer-before-symptoms-show-302293287.html) | [[PR Newswire]] | | 10/31/2024 | [**Lung Cancer Screening May Detect Cancer Before Symptoms Show**](https://www.morningstar.com/news/pr-newswire/20241101dc45679/lung-cancer-screening-may-detect-cancer-before-symptoms-show) | [[Morningstar]] | | 10/25/2024 | [**New lung cancer screening model removes barriers for central Texas' most vulnerable**](https://medicalxpress.com/news/2024-10-lung-cancer-screening-barriers-central.html) | [[MedicalXpress]] | | 10/6/2024 | [**CHEST Data Show Low Lung Cancer Screening Awareness in Underserved Communities: Dr Juan Carlos Martinez**](https://www.ajmc.com/view/chest-data-show-low-lung-cancer-screening-awareness-in-underserved-communities-dr-juan-carlos-martinez) | [[AJMC]] | | 9/25/2024 | [**Lung Cancer Screening Software Market Growth, Trends and Forecast to 2032 - Medium**](https://medium.com/@davidthamus55/lung-cancer-screening-software-market-growth-trends-and-forecast-to-2032-c554fb8dfe85) | [[Medium]] | | 7/3/2024 | [**Medical College of Wisconsin: Set to lead key initiative as part of EDA Tech Hub Phase 2 funding**](https://www.wisbusiness.com/2024/medical-college-of-wisconsin-set-to-lead-key-initiative-as-part-of-eda-tech-hub-phase-2-funding/) | wisbusiness.com | | 6/10/2024 | [**Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South**](https://www.medpagetoday.com/radiology/diagnosticradiology/110566) | [[Medpage Today]] | | 5/30/2024 | [**Data Show Disadvantaged Groups Have Significant Need for Lung Cancer Screening**](https://www.pharmacytimes.com/view/data-show-disadvantaged-groups-have-significant-need-for-lung-cancer-screening) | [[Pharmacy Times]] | | 10/31/2023 | [**American Cancer Society expands lung cancer screening guidelines for cigarette smokers**](https://www.statnews.com/2023/11/01/lung-cancer-screening-smokers-american-cancer-society/) | [[STAT]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **American Cancer Society**: An organization advocating for lung cancer awareness and screening, recommending annual low-dose CT scans for high-risk individuals. - **American Lung Cancer Screening Initiative (ALCSI)**: An initiative aimed at promoting awareness and access to lung cancer screening. - **Lahey Hospital & Medical Center**: A recognized leader in lung cancer screening, designated by the American College of Radiology. - **Dr. Juan Carlos Martinez**: Discussed awareness gaps regarding lung cancer screening methods among patients. - **Nichole Tanner, MD**: Presented a centralized lung cancer screening approach within the Veterans Health Administration, highlighting the need for screening among veterans. - **Harry de Koning, MD**: Expert discussing recruitment strategies for lung cancer screening, emphasizing patient registries and socioeconomic factors. - **Dr. Jason Spangler**: Highlighted equity challenges in health technology assessment related to lung cancer screening. - **UVA Cancer Center**: Partnered with local organizations to enhance lung cancer screening access in rural areas. - **UK Healthcare's Markey Cancer Center**: Received funding to replicate successful lung cancer screening programs in other states. - **LUNGevity Foundation**: A nonprofit organization focused on improving lung cancer outcomes through research, education, and advocacy. - **Wake Radiology UNC Health Rex**: A designated Lung Cancer Screening Center in North Carolina, promoting awareness and accessibility of lung cancer screenings. - **Delfi Diagnostics**: A company specializing in liquid biopsy tests for lung cancer screening, aiming to improve early detection. - **Temple Health**: Operates the Healthy Chest Initiative, utilizing low-dose CT scans to detect lung cancer and other chest morbidities. - **Median Technologies**: Developing AI-based lung cancer screening software, eyonis™ LCS, expected to launch in the U.S. in late 2025. - **U.S. Preventive Services Task Force (USPSTF)**: An independent panel of experts that makes evidence-based recommendations about clinical preventive services, including lung cancer screening guidelines. - **Coreline Soft**: A provider of AI-based medical solutions, entering the Australian market to enhance lung cancer screening initiatives. - **Olympus Corp. of the Americas**: A company supporting lung cancer awareness initiatives and advocating for improved access to lung cancer screenings. - **DELFI Diagnostics, Inc.**: A biotechnology company focused on developing blood-based tests for early cancer detection, including lung cancer screening. ### Partnerships and Collaborations - **CancerIQ & Healthcare Providers**: Utilizing campaign-based marketing to identify high-risk individuals for lung cancer screening. - **American Cancer Society and Iowa Cancer Consortium**: Collaborating to form a Lung Cancer Screening Learning Collaborative Series aimed at increasing screening rates. - **Florida Lung Health Coalition and DELFI Diagnostics**: Initiative to improve lung cancer screening rates in Florida, offering a FirstLook Lung test followed by low-dose CT scans. - **LUNGevity Foundation and ALCSI**: Partnering to promote lung cancer awareness during Lung Cancer Awareness Month with events in major cities. - **DELFI Diagnostics & Lahey Hospital**: Collaborating to implement the FirstLook Lung cancer screening test in the greater Boston area. - **Coreline AI and Temple Health**: Collaboration to enhance lung cancer screening through AI integration in the Healthy Chest Initiative. - **Bristol Myers Squibb Foundation and UCLA**: Funding the CAL-PALS initiative to reduce lung cancer screening disparities in Los Angeles County. - **UVA Cancer Center & Appalachian Community Cancer Alliance**: Formed the Rural Appalachian Lung Cancer Screen Initiative to improve screening access in rural Virginia and West Virginia. - **Allegheny Health Network and DELFI Diagnostics**: Collaborating to assess the effectiveness of the FirstLook blood test for lung cancer screening. - **bioAffinity Technologies and Veterans Health Administration**: Collaboration to enhance lung cancer screening and diagnosis using CyPath® Lung for veterans. - **GE HealthCare Technologies Inc. and DeepHealth**: Partnering to enhance imaging through AI, with potential future applications in lung cancer screening. - **Dell Medical School and CommUnityCare Health Centers**: Central Texas initiative aimed at reducing disparities in lung cancer outcomes through patient-centered approaches. - **Coreline Soft and ParagonCare**: Strategic partnership to enhance lung cancer screening initiatives in Australia, leveraging AI technology. - **Viz.ai and Guardant Health**: Proposed collaboration to integrate AI and genomic insights for improving lung cancer detection and treatment decisions. - **bioAffinity Technologies, Inc.**: Announced the addition of its noninvasive test, CyPath® Lung, to the U.S. Federal Supply Schedule for easier access for Veterans. - **GE Healthcare and DeepHealth**: Collaborating to develop AI imaging technology for enhanced cancer screening and diagnostics. - **WellSpan Health and Hippocratic AI**: A partnership to launch a clinical GenAI healthcare agent to enhance patient interaction and access to cancer screenings. - **BPI France and HEPTA Medical**: BPI France led a Series A funding round to support HEPTA Medical's lung cancer treatment technology development. - **Aidoc and Integral Diagnostics**: Enhancing radiology services in Australia and New Zealand through AI technology. - **Aidoc and Integral Diagnostics (IDX)**: Collaboration to enhance radiology services in Australia and New Zealand, improving patient care through AI technology. ### Innovations, Trends, and Initiatives - **National Lung Cancer Screening Program in Australia**: Set to begin in July 2025, focusing on high-risk individuals to improve early detection and reduce mortality. - **Low-Dose Computed Tomography (LDCT)**: The only recommended screening method for lung cancer, advised for high-risk adults without symptoms. - **Lung Cancer Awareness Month**: November is designated for raising awareness about lung cancer, emphasizing the importance of screening and early detection. - **Rural Appalachian Lung Cancer Screen Initiative**: Aimed at streamlining referral processes for lung cancer screenings in underserved areas. - **Integrated Care for Smoking Cessation**: Studies show that combining lung cancer screening with smoking cessation support significantly improves quit rates. - **AI in Lung Cancer Screening**: Innovations include AI platforms that analyze 3D low-dose CT scans to detect lung nodules, improving screening rates and diagnostic accuracy. - **FirstLook Lung test**: A highly sensitive blood test designed to identify patients who would benefit from LDCT screening. - **Veterans Health Administration Mandate**: Requires all eligible veterans to be offered lung cancer screening, reflecting the need for early detection in this demographic. - **Lung Cancer Screening Software Market**: Projected to grow significantly, driven by increased lung cancer cases and demand for AI technologies. - **Mobile Screening Units**: Proposed solutions to improve access to lung cancer screenings in underserved and rural areas. - **Text Messaging for Screening**: Research on using text messaging to assess lung cancer screening eligibility highlights the need for multimodal approaches to ensure equity. - **CAL-PALS Initiative**: A program aimed at enhancing access to lung cancer screening for marginalized groups through community hospitals. - **CyPath® Lung**: A noninvasive test for early-stage lung cancer detection that could lead to significant cost savings in healthcare. - **AI and Machine Learning in Screening**: Technological advancements are improving the sensitivity and specificity of lung cancer detection, facilitating earlier diagnoses. - **Biomarker Testing**: Research indicates that biomarker testing can significantly reduce lung cancer deaths, highlighting its potential in early detection. - **FirstLook Lung Test**: A blood-based test utilizing fragmentomics and machine learning to detect lung cancer with high sensitivity and a negative predictive value of 99.8%. - **PanCan Protocol**: A new nodule management protocol that outperforms LungRADSv1.1 in triaging lung cancer screening participants, showing better risk stratification. - **AI-Driven Diagnostic Tools**: Innovations in AI are enhancing disease detection and diagnosis, particularly in lung cancer screening. ### Challenges and Concerns - **Low Screening Rates**: Despite advancements, only 18% of eligible individuals in the U.S. undergo lung cancer screenings, highlighting barriers such as complex eligibility criteria and lack of primary care providers. - **Access to Screening**: Concerns about equitable access to lung cancer screening, particularly among racial and ethnic minority groups. - **Over-diagnosis Risks**: Concerns regarding the effectiveness of lung cancer screening for non-smokers and low-risk individuals, highlighting the need for more rigorous research. - **Awareness Gaps**: A significant percentage of eligible individuals are unaware of lung cancer screening recommendations, indicating a need for better education and outreach. - **Access to Care**: Many eligible individuals lack access to primary care practitioners, hindering lung cancer screening uptake. - **Racial Disparities**: Current screening guidelines may contribute to racial disparities in lung cancer diagnosis, particularly affecting Black patients. - **Awareness and Access**: Significant gaps in awareness regarding lung cancer screening methods among patients, particularly in underrepresented communities. - **Screening Criteria Limitations**: Current U.S. Preventive Services Task Force criteria may overlook individuals who could benefit from lung cancer screening. - **Access for Rural Residents**: Challenges such as distance to screening centers and lower health literacy create barriers for rural populations in accessing lung cancer screenings. - **Potential Harms of Screening**: Concerns exist regarding unnecessary procedures and psychological impacts from false positives in lung cancer screening. - **Socioeconomic Barriers**: Multilevel barriers to lung cancer screening, including language, education, and healthcare access, impacting uptake and early disease identification. - **Disparities in Screening**: Current guidelines primarily focus on smokers, potentially overlooking at-risk nonsmokers, particularly among specific demographic groups. - **Resource-Intensive Care Models**: Integrated care models for smoking cessation linked to lung cancer screening may not be feasible in all healthcare settings. - **High Operational Costs**: Mobile lung cancer screening units face high operational costs, which may limit their implementation. - **E-Cigarette Use Impact**: Current e-cigarette users are less likely to undergo lung cancer screening, raising concerns about awareness and adherence to guidelines. - **Confusing Screening Guidelines**: Existing guidelines based on smoking history may be confusing and miss significant cases. - **Health Equity**: Ensuring participation in cancer screenings among underserved communities remains a challenge despite technological advancements. - **Regulatory Approval**: The FirstLook Lung test has not yet received FDA clearance, which is crucial for widespread adoption. ## Related Topics [[Cancer Screening]]